MedPath

Sweet Consumption and Subsequent Sweet Food Preferences and Intakes

Not Applicable
Completed
Conditions
Dietary Behaviour
Registration Number
NCT05672017
Lead Sponsor
Bournemouth University
Brief Summary

This study will assess the effects of repeated sweet versus non-sweet food consumption on subsequent sweet and non-sweet food preferences and intakes.

Detailed Description

Participants will be randomized to receive instructions to either increase, decrease or make no change to sweet food consumption for 6 days, and impacts on food preferences and intakes will be assessed at baseline and after 1 week. Preferences for sweet and non-sweet foods will be assessed during a taste test at each assessment time, where six different foods will be rated. Sweet and non-sweet food consumption will also be measured at a subsequent breakfast at the assessment time. Buffet meals composed of sweet and non-sweet foods suitable for consumption at breakfast will be provided ad-libitum.

A subset of participants (selected at random) (10 participants randomized to increase sweet food consumption and 10 participants randomized to decrease sweet food consumption) will also be assessed via MRI and fMRI scanning to investigate brain structure and functional connectivity.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
104
Inclusion Criteria
  1. aged 18-65 years;
  2. habitually consume breakfast;
  3. able to provide consent and complete all study materials;
  4. able to attend Bournemouth University for testing.

Exclusion criteria:

  1. individuals who are pregnant or breastfeeding;
  2. underweight (BMI <18.5);
  3. have pre-existing clinical conditions such as diabetes mellitus, eating disorders, Crohn's disease and other illness's leading to participants receiving external nutritional advice and dietary restrictions;
  4. have pre-existing medical conditions affecting swallow ability, taste and smell perception;
  5. currently or within 3 months of starting the study are following a specific dietary programme (e.g.: Slimming World);
  6. current smokers or have smoked within 3 months of the study start date.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Sweet Food PreferencesWeek 1

Preferences for various sweet foods/fluids, assessed using a taste test, where participants sample several sweet and non-sweet foods and rate them for pleasantness on a 100mm Visual Analogue Scale, from 0 to 100mm. Higher scores signify stronger preferences

Sweet Food ChoicesWeek 1

Selection of sweet foods/fluids at a given meal, assessed where participants can consume freely from a meal composed of sweet and non-sweet foods, and proportion of sweet foods consumed is measured as a percentage of weight consumed

Secondary Outcome Measures
NameTimeMethod
Hunger and ThirstWeek 1

Ratings of subjective perceptions, assessed using 100mm VAS from 0 (lower hunger) to 100 (higher hunger) mm

Sweet Food PerceptionsWeek 1

Perceptions for various sweet foods/fluids, assessed using a taste test, where participants sample several sweet and non-sweet foods and rate them for intensity on a 100mm Visual Analogue Scale from 0 to 100mm. Higher scores signify stronger perceptions

MRI Static Brain Scan (Subset of Participants Only)Baseline to week 1

Static brain scan gained from a 3-Tesla Siemens Magnetom Lumina scanner (Siemens Healthcare, Erlangen, Germany), used to investigate brain structure, where the anatomical structure (e.g. size, shape) of the brain, measured via surface area (mm squared), will be compared at baseline and week 1

fMRI Composite Functional Brain Scan (Subset of Participants Only)Baseline to week 1

Composite fMRI functional scan to investigate brain functionality and connectivity in response to a 10 min cognitive task, will be gained from a 3-Tesla Siemens Magnetom Lumina scanner (Siemens Healthcare, Erlangen, Germany), where patterns of activity will be measured using blood oxygenation level-dependent (BOLD) contrast whole-brain functional images, acquired using a T2-weighted gradient-echo Echo Planar Imaging (EPI) sequence and a 32-channel head coil during a 10 min cognitive task, and will be compared at baseline and week 1 (for full details of this methodology see Yankouskaya A, et al., Biology, 2023, 12, 211.)

Trial Locations

Locations (1)

Bournemouth University

🇬🇧

Bournemouth, US And Canada Only, United Kingdom

Bournemouth University
🇬🇧Bournemouth, US And Canada Only, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.